Paramyxoviruses 
 Paramyxoviruses 
 Paramyxoviridae 
- Paramyxovirus - parainfluenza, mumps
- Pneumovirus - respiratory syncytial virus
 Rubella virus is a member of the Togaviridae!!! 
 Structure: Paramyxoviridae 
- helical, pleomorphic symmetry
- SS RNA ,antisense  monopartite
 PPT Slide 
 Viral Proteins 
- RNA-directed RNA polymerase
 Neuraminidase & hemagglutinin activities are different sites of the same protein 
 Fusion protein  causes syncytia formation 
 Multiplication 
- Antisense strand -> sense RNA  
- RNA directed RNA polymerase
 
- sense RNA template for antisense strands
 Paramxyovirus 
 Parainfluenza Viruses 
 Paraflu:Clinical manifestions 
- mild or severe infections
- lower and upper respiratory tract
 Paraflu: Classification 
 Paraflu: Epidemiology 
- primarily in young children
 Paraflu: Diagnosis 
- clinical symptoms nonspecific
- Detect rise in specific antibodies
 No vaccine is available for Parainfluenza 
 Mumps virus 
 Mumps:Clinical manifestions 
- systemic febrile infection
- swelling of salivary glands
- orchitis oophoritis in adults
 Single mumps serotype   
- shared antigens with paraflu type 1
 Mumps:Pathogenesis 
- spreads to glands & nervous tissue
- inflammation & cell death
 Mumps:Epidemiology 
- intermittant in rural areas
 Mumps:Diagnosis 
- viral antigen in saliva of CSF
- Detect rising titer of IgG
 Mumps: Defenses 
 Mumps:Control 
 Morbillivirus 
 Measles: Clinical manifestions 
- coryza, conjunctivitis, fever rash
- maculopapular rash 1-3 days later
- otitis, pneumonia, encephalitis
- SSPE (subacute sclerosing panencephalitis)-rare
 Measles: Pathogenesis 
- multiples in cells of :
- lymphatic system
- respiratory system
- skin
- brain
 
 Measles:Host Defenses 
 Measles: Epidemiology 
- mainly late winter-early spring
 Measles Incidence 
 Measles: Diagnosis 
 Measles: Control 
- Live attentuated virus vaccine
- measles hyperimmunoglobulin
 WHO MeaslesVaccination Strategy 
- "catch-up" everyone aged 1-14 years
- "keep-up"  90% of children at age 12 months; 
 Pneumovirus 
Respiratory syncytial virus
 RSV:Clinical manifestions 
- upper & lower respiratory tract infection
- frequent in young children
 RSV: Pathogenesis 
- infects ciliated epithelium of respiratory mucosa
Antibody Dependent Cytotoxicity
 RSV: Host Defenses 
- Secretory immunity ( sIgA)
 RSV: Epidemiology 
- epidemic winter and early spring
 RSV: Diagnosis 
- nonspecific clinical symptoms
 RSV: Control 
- isolate patients in hospitals